Join
Live feed
·
PRReleasevia Quantisnow
GSK plc logo
Pfizer Inc. logo

ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention

ByQuantisnow·Wall Street's wire, on your screen.
GSK· GSK plcPFE· Pfizer Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GSK (GSK plc), PFE (Pfizer Inc.) and more on Quantisnow.